Protocol for Women at Increased Risk of Developing Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

A pilot study to assess the effects of six months of letrozole on breast tissue risk markers in postmenopausal women on hormone replacement therapy at high risk of developing breast cancer.

Key facts

Study ID

NCT00291135

Run by

Carol Fabian, MD

People needed

42

Starts

2003-01-01

Expected to finish

2008-10-01

Last updated by the study team

2016-06-15

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• evidence of hyperplasia with/without atypia upon random periareolar fine needle aspiration of breast
• on hormone replacement therapy
• postmenopausal
• increased risk of developing breast cancer based on personal or family history
• never have taken aromatase inhibitors or selective estrogen receptor modulators in last six months
• women who have a high risk of breast cancer
• older than 18 years

You may not qualify if…

• anticoagulants
• marked breast tenderness
• pregnant or within twelve months of breast feeding/childbirth

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.